Synthetic genomics for curing genetic diseases.

Area of Science:

• Genomics
• Medical Genetics
• Bioengineering

Background:

• Genetics influences all diseases, but current gene therapies primarily target rare single-gene disorders.
• Over 6000 diseases are linked to genes, with most genetic disorders being rare and poorly understood.
• Congenital genetic mutations cause health problems for a significant portion of the population.

Purpose of the Study:

• To explore potential therapies for genetic diseases from a chromosome and genome-scale perspective.
• To shift focus from small gene corrections to higher-order genome manipulation tools.
• To highlight the role of advanced genome manipulation in understanding disease and developing new treatments.

Main Methods:

• Reviewing the potential of genome synthesis technologies.
• Discussing higher-order genome manipulation strategies.
• Examining advancements in understanding human genome architecture.

Main Results:

• Genome-scale approaches can address unmet medical needs in genetic disease therapy.
• Higher-order genome manipulation tools are crucial for future therapeutic development.
• Advanced techniques provide deeper insights into human genome architecture and disease modeling.

Conclusions:

• Shifting therapeutic focus to genome-scale manipulation opens new avenues for treating complex genetic disorders.
• Understanding genome architecture through advanced tools will lead to more accurate disease models.
• These advancements promise novel therapeutic opportunities for a wide range of genetic conditions.